What is he best known for?
The fields of study he is best known for:
Ola Blixt mainly investigates Glycan, Biochemistry, Virology, Influenza A virus subtype H5N1 and Glycoprotein.
His Glycan research is multidisciplinary, incorporating elements of Biophysics, Proteomics and Systems biology.
His study on Biochemistry is mostly dedicated to connecting different topics, such as Sialic Acid Binding Immunoglobulin-like Lectins.
His work in the fields of Hemagglutinin, Virus and Influenza A virus overlaps with other areas such as Systematic evolution of ligands by exponential enrichment.
His work deals with themes such as Mutation, Receptor, Sialic acid and Recombinant DNA, which intersect with Hemagglutinin.
His research links Glycolipid with Glycoprotein.
His most cited work include:
- Printed covalent glycan array for ligand profiling of diverse glycan binding proteins (925 citations)
- Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus (861 citations)
- Glycan Microarray Analysis of the Hemagglutinins from Modern and Pandemic Influenza Viruses Reveals Different Receptor Specificities (563 citations)
What are the main themes of his work throughout his whole career to date?
Ola Blixt spends much of his time researching Glycan, Biochemistry, Antibody, Virology and Epitope.
His Glycan study introduces a deeper knowledge of Glycoprotein.
His Antibody study incorporates themes from Molecular biology and Antigen.
His work on Influenza A virus subtype H5N1, Virus, Influenza a and Avian influenza virus as part of general Virology research is frequently linked to Population, thereby connecting diverse disciplines of science.
His work in Influenza A virus subtype H5N1 addresses subjects such as Hemagglutinin, which are connected to disciplines such as Receptor.
His Epitope research includes themes of Viral envelope and Peptide library, Peptide sequence.
He most often published in these fields:
- Glycan (34.92%)
- Biochemistry (32.54%)
- Antibody (24.60%)
What were the highlights of his more recent work (between 2018-2021)?
- Glycan (34.92%)
- Virology (19.84%)
- Antibody (24.60%)
In recent papers he was focusing on the following fields of study:
Ola Blixt mostly deals with Glycan, Virology, Antibody, Epitope and Influenza A virus.
His study in Glycan is interdisciplinary in nature, drawing from both Analyte, Graphene and Biosensor.
Ola Blixt has researched Virology in several fields, including Attenuated vaccine, Glycosylation and Vaccine efficacy.
Ola Blixt combines subjects such as Glycolipid, Biochemistry, Breast milk and Glycoprotein with his study of Antibody.
His Biochemistry study frequently involves adjacent topics like Chemical design.
The Influenza A virus study combines topics in areas such as Zoology, Anas, Influenza A virus subtype H5N1 and Outbreak.
Between 2018 and 2021, his most popular works were:
- Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures (5 citations)
- Specificity of human natural antibodies referred to as anti-Tn. (4 citations)
- The Repertoire of Human Antiglycan Antibodies and Its Dynamics in the First Year of Life. (3 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Glycan, Antibody, Chinese hamster ovary cell, Breast milk and Microarray.
Many of his studies on Glycan involve topics that are commonly interrelated, such as Tn antigen.
His Tn antigen study integrates concerns from other disciplines, such as Biochemistry, Peptide sequence, Affinity chromatography and Epitope, Paratope.
His Chinese hamster ovary cell research is multidisciplinary, incorporating perspectives in Glycosylation, Attenuated vaccine, Virus, Varicella zoster virus and Vaccine efficacy.
His Varicella zoster virus study is concerned with Virology in general.
His studies deal with areas such as Glycolipid, Immunology, Antigen and Glycoprotein as well as Breast milk.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
